pr web

BitMEX Report Finds 500%+ Increase in Tokenised Commodities and Equity Perpetuals

by

BitMEX Report Finds 500%+ Increase in Tokenised Commodities and Equity Perpetuals BitMEX has released its Q1 2026 derivatives report, highlighting a sharp rise in trading activity for traditional finance perpetual swaps (TradFi Perps), driven by increased demand for tokenised commodities and equities. VICTORIA, Seychelles, April 09, 2026 (GLOBE NEWSWIRE) — BitMEX has released its Q1 … Read more

BitMEX Debuts New Mobile Trading Experience With Intuitive Design and Controls

by

BitMEX Debuts New Mobile Trading Experience With Intuitive Design and Controls VICTORIA, Seychelles, Dec. 11, 2025 (GLOBE NEWSWIRE) — BitMEX, one of the safest crypto exchanges, today announced significant upgrades to its mobile app, introducing a redesigned interface and new interaction model intended to support faster, clearer and more intuitive crypto derivatives trading on the … Read more

All Set for the 1000 Miglia 2025

by

The Most Beautiful Race in the World Returns to Italian Roads Press Conference Mille Miglia – June 13th, 2025 – Brescia, Italy BRESCIA, Italy, June 13, 2025 (GLOBE NEWSWIRE) — The countdown is almost over. The 1000 Miglia returns, 17-21 June with an eight-shaped route inspired by the epic pre-war editions, linking the eastern Adriatic and western Tyrrhenian coasts, besides the … Read more

ZBIO IMPORTANT DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Zenas BioPharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 16 Deadline in Securities Class Action First Filed by the Firm – ZBIO

by

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zenas BioPharma, Inc. (NASDAQ: ZBIO) pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with Zenas BioPharma’s September 2024 initial public offering (“IPO” or the … Read more

Facephi accelerates the digitalization of the air travel with verified identity and its KYP (Know Your Passenger) solution at the IATA World Data Symposium

by

KYP IATA Facephi digital Identity seamless travel MADRID, March 12, 2025 (GLOBE NEWSWIRE) — Facephi, a leading company in digital identity technology, has reinforced its commitment to transforming the aviation sector at the IATA World Data Symposium. At this key industry event, the company showcased several solutions aimed at enabling a fully digital air travel … Read more

OCTO has been selected by ABAX Group as its New Risk Scoring Partner for UBI Insurance

by

LARVIK, Norway, March 11, 2025 (GLOBE NEWSWIRE) — Following an extensive six-month RFP process, ABAX Group AS announced today that its insurance division, “Fair” has selected OCTO Telematics, a leading global provider of AI and risk scoring solutions, to support its rapidly growing portfolio of Usage-Based Insurance (UBI) customers. This strategic partnership enhances its insurance product with improved AI-powered analytics, enabling more precise risk … Read more

20% of Gen Z and Alpha Open to Crypto-Based Pensions, Bitget Research Finds

by

20% of Gen Z and Alpha Open to Crypto-Based Pensions, Bitget Research Finds VICTORIA, Seychelles, Jan. 16, 2025 (GLOBE NEWSWIRE) — A new report from Bitget Research, the analytical division of the world’s leading cryptocurrency exchange and Web3 company Bitget, reveals a significant shift in retirement planning trends among younger generations. According to the study, 20% … Read more

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – APLT

by

NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics … Read more